Association of Ephrin receptor A3 gene polymorphism with susceptibility to chronic severe hepatitis B

Hepatology Research

Volumn 42, Issue 8, 2012, Pages 790-797

  Yang, Hong ^a   He, Xing Xing ^a   Song, Qi Long ^a   Chen, Man ^a   Li, Jin ^a   Wang, Meng Yi ^a   Yu, Jin Ling ^a   Yao, Jin Jian ^a   Liu, Li Feng ^a   Lin, Ju Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic severe hepatitis B; Ephrin receptor A3; Hepatitis B virus; Polymorphism

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; EPHRIN RECEPTOR A3; GENOMIC DNA; HEPATITIS B SURFACE ANTIGEN; PROTHROMBIN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION SENSITIVITY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS CARRIER;

EID: 84863765310     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.00977.x     Document Type: Article

References (38)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 11: 1733-45.
2. He XX, Chen T, Lin JS, Chang Y, Ye BX. Inhibition of the replication of hepatitis B virus in vitro by a novel 2, 6-diaminopurine analog, beta-LPA. Biochem Biophys Res Commun 2008; 2: 513-8.
3. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 2001; 52: 113-6.
4. Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes. Hepatology 2002; 35: 1274-6.
5. Sun Z, Lu P, Gail MH etal. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 1999; 30: 379-83.
6. Hann HW, Kim CY, London WT, Whitford P, Blumberg BS. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea. Int J Cancer 1982 (Jul); 15 (30): 47-51.
7. Lin TM, Chen CJ, Wu MM etal. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9: 737-41.
8. Shimbo S, Zhang ZW, Qu JB etal. Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong Province, China. Southeast Asian J Trop Med Public Health 1997; 28: 500-6.
9. Ben-Ari Z, Mor E, Papo O etal. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144-50.
10. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-82.
11. Shin HD, Park BL, Kim LH etal. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003; 15: 901-6.
12. Tseng LH, Lin MT, Shau WY etal. Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens 2006; 67: 127-33.
13. Bellamy R, Ruwende C, Corrah T etal. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-4.
14. Bae HJ, Song JH, Noh JH etal. Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma. Neoplasma 2009; 56: 331-4.
15. Davies H, Hunter C, Smith R etal. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 2005 (Sep); 1 (65): 7591-5.
16. Bardelli A, Parsons DW, Silliman N etal. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003; 9: 949.
17. Bonifaci N, Gorski B, Masojc B etal. Exploring the link between germline and somatic genetic alterations in breast carcinogenesis. PLoS ONE 2010; 5: e14078.
18. Lee JS, Thorgeirsson SS. Comparative and integrative functional genomics of HCC. Oncogene 2006; 26: 3801-9.
19. Nam SW, Park JY, Ramasamy A etal. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005; 42: 809-18.
20. Wu J, Luo H. Recent advances on T-cell regulation by receptor tyrosine kinases. Curr Opin Hematol 2005; 12: 292-7.
21. Sharfe N, Freywald A, Toro A, Dadi H, Roifman C. Ephrin stimulation modulates T cell chemotaxis. Eur J Immunol 2002; 32: 3745-55.
22. Liu L, Li J, Yao J etal. A genome-wide association study with DNA pooling identifies the variant rs11866328 in the GRIN2A gene that affects disease progression of chronic HBV infection. Viral Immunol 2011; 24: 397-402.
23. Lovmar L, Ahlford A, Jonsson M, Syvanen AC. Silhouette scores for assessment of SNP genotype clusters. BMC Genomics 2005; 6: 35.
24. Pearson JV, Huentelman MJ, Halperin RF etal. Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. Am J Hum Genet 2007; 80: 126-39.
25. Zeng Z, Guan L, An P, Sun S, O'Brien SJ, Winkler CA. A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis 2008; 8: 1.
26. He XX, Chang Y, Jiang HJ etal. Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol 2010; 23: 251-7.
27. Huang K, Hu JH, Wang HF etal. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011; 7 (17): 3448-52.
28. Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011 (Mar); 53: 774-80.
29. Kusumoto S, Tanaka Y, Ueda R, Mizokami M. Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy. J Gastroenterol 2010 (Jan); 46: 9-16.
30. Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 2009; 90: 13-23.
31. Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B etal. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol 2002 (Mar); 1 (168): 2240-6.
32. Aasheim HC, Terstappen LW, Logtenberg T. Regulated expression of the Eph-related receptor tyrosine kinase Hek11 in early human B lymphopoiesis. Blood 1997 (Nov); 1 (90): 3613-22.
33. Shimoyama M, Matsuoka H, Tamekane A etal. T-cell-specific expression of kinase-defective Eph-family receptor protein, EphB6 in normal as well as transformed hematopoietic cells. Growth Factors 2000; 18: 63-78.
34. Ivanov AI, Steiner AA, Scheck AC, Romanovsky AA. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats. Physiol Genomics 2005 (Apr); 14 (21): 152-60.
35. Ivanov AI, Romanovsky AA. Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life 2006; 58: 389-94.
36. Deng G, Zhou G, Zhai Y etal. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004; 40: 318-26.
37. Wang N, Zheng Y, Yu X, Lin W, Chen Y, Jiang Q. Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer. Am J Epidemiol 2009; 15: 990-5.
38. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009; 50: 1392-402.